New Issue: Orbital Catastrophe Ahead? Read Now

Anthony Fauci

The public health expert and former federal health official talks about the politicization of science

Anthony Fauci's side profile and his reflection, next to an American flag.

Tom Williams/CQ-Roll Call, Inc via Getty Images

This article is part of “The Young American Scientists,” which includes stories of 28 extraordinary scientists poised to change the world, as well as a deep look at the past, present and future of science and innovation in the U.S.

Join Our Community of Science Lovers!

Anthony Fauci is an American physician-scientist who led the National Institute of Allergy and Infectious Diseases from 1984 to 2022 and served as a key public health adviser during multiple disease outbreaks, including HIV/AIDS, Ebola and COVID.

[This interview was edited for length and clarity.]

How would you describe the current state of American science?


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The current state of American science is generally quite good. But the recent politicization of science by current leadership at the U.S. Department of Health and Human Services and the National Institutes of Health, as well as their attempts (unsuccessful so far) to significantly reduce the allocation of resources to the NIH pose a serious threat to our standing as the leading country in the area of biomedical research.

What needs to change in American science?

Even stronger pushback is needed against attempts to downgrade the government-sponsored biomedical research efforts, including what appears to be a weakening of peer review in favor of decision-making by political appointees.

What gives you optimism right now?

I am buoyed by the brilliance and energy of our younger generation in the field of science in general and biomedical research specifically. In addition, the opportunities for major transforming advances in biomedical research are greater today than they have ever been because of technologies such as mRNA platforms, artificial-intelligence-accelerated discovery, systems immunology, engineered antibodies and immune modulators, and CRISPR and other next-generation diagnostics.

What’s your best advice for an early-career scientist?

My advice to early career scientists is to follow your passion and not be discouraged by the current stress on the system. The opportunities and sources of gratification and accomplishment that await you will be very fulfilling and rewarding. And along the way, do not forget to have some fun!

How has your field changed in the past few years?

My own field of the interface of infectious diseases and the immune system has been transformed in the past few years with technological advances that were unimaginable years ago. For example, with the help of AI, we are no longer just fighting infections—we are learning to anticipate them, model them and even design immunity against them.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe